REFERENCES
- Lee JJY, Schneider R. 2018 Aug. Systemic Juvenile Idiopathic
Arthritis. Pediatr Clin North
Am. 65(4):691-709.
- Buckley MM, Rabinovich CE. 2021 Feb. Pulmonary Manifestations of
Rheumatic Diseases in Children.
Pediatr Clin North Am.
68(1):147-166.
- Richardson AE, Warrier K, Vyas H. 2016 Aug. Respiratory complications
of the rheumatological diseases in childhood. Arch Dis Child.
101(8):752-758.
- Saddi V, Beggs S, Bennetts B,
Harrison J, Hime N, Kapur N, Lipsett J, Nogee LM, Phu A, Suresh S, et
al. 2017 Jul 25. Childhood interstitial lung diseases in
immunocompetent children in Australia and New Zealand: a decade’s
experience. Orphanet J Rare Dis. 12(1):133.
- Dinwiddie R, Sharief N, Crawford O. 2002 Jul. Idiopathic interstitial
pneumonitis in children: a national survey in the United Kingdom and
Ireland. Pediatr Pulmonol.
34(1):23-29.
- Schulert GS, Yasin S, Carey B,
Chalk C, Do T, Schapiro AH, Husami A, Watts A, Brunner HI, Huggins J,
et al. 2019 Nov. Systemic Juvenile Idiopathic Arthritis-Associated
Lung Disease: Characterization and Risk Factors. Arthritis Rheumatol.
71(11):1943-1954.
- Pelucchi A, Lomater C,
Gerloni V, Foresi A, Fantini F,
Marazzini L. 1994. Lung
function and diffusing capacity for carbon monoxide in patients with
juvenile chronic arthritis: effect of disease activity and low dose
methotrexate therapy. Clin Exp Rheumatol. 12(6):675-679.
- Athreya BH, Doughty RA, Bookspan M, Schumacher HR, Sewell EM, Chatten
J. 1980 Sep. Pulmonary manifestations of juvenile rheumatoid
arthritis. A report of eight cases and review. Clin Chest Med.
1(3):361-374.
- Saper VE, Chen G, Deutsch GH, et al. Emergent high fatality lung
disease in systemic juvenile arthritis. Ann Rheum Dis.
2019;78(12):1722-1731.
- Kimura Y, Weiss JE, Haroldson KL, et al. Pulmonary
hypertension and other
potentially fatal pulmonary complications in systemic juvenile
idiopathic arthritis. Arthritis Care Res (Hoboken).
2013;65(5):745-752.
- Foeldvari I, Bidde M. 2000 Apr.
Validation of the proposed ILAR classification criteria for juvenile
idiopathic arthritis. International League of Associations for
Rheumatology. J Rheumatol. 27(4):1069-1072.
- Yasin S, Fall N, Brown RA, Henderlight M, Canna SW,
Girard-Guyonvarc’h C, Gabay C,
Grom AA, Schulert GS. Il-18 as
a biomarker linking systemic juvenile idiopathic arthritis and
macrophage activation syndrome. Rheumatology. 2019;59(2):361–366.
doi:10.1093/rheumatology/kez282.
- Chen G, Deutsch GH, Schulert G,
et al. Serum proteome analysis of systemic JIA and related lung
disease identifies distinct inflammatory programs and biomarkers.
Arthritis Rheumatol. Published
online February 21, 2022.
- Wambach JA, Young LR. New clinical practice guidelines on the
classification, evaluation and
management of childhood interstitial lung disease in infants: what do
they mean? Expert Rev Respir Med. 2014;8(6):653-655.
-
- DiPrete O, Winant AJ, Vargas
SO,
Rameh V, Chaturvedi A, Lee EY.
Advances in Imaging of the ChILD - Childhood Interstitial Lung
Disease. Radiologic Clinics of North America. 2022;60(6):1003–1020.
doi:10.1016/j.rcl.2022.06.008
- Vega‐Fernandez P, Ting TV, Mar DA, Schapiro AH, Deluna MD, Saper VE,
Grom AA, Schulert GS, Fairchild
RM. Lung ultrasound in children with systemic juvenile idiopathic
arthritis–associated interstitial lung disease. Arthritis Care and
Research. 2022 May 23. doi:10.1002/acr.24957
- Hafezi N, Heimberger MA, Lewellen KA, Maatman T, Montgomery GS, Markel
TA. Lung biopsy in children’s interstitial and diffuse lung disease:
Does it alter management? Pediatric Pulmonology.
2020;55(4):1050–1060. doi:10.1002/ppul.24683
- Erkens R, Esteban Y, Towe C,
Schulert G,
Vastert S.
Pathogenesis and treatment of
refractory disease courses in systemic juvenile idiopathic arthritis.
Rheumatic Disease Clinics of North America. 2021;47(4):585–606.
doi:10.1016/j.rdc.2021.06.003
- Alkady EA, Helmy HA,
Mohamed-Hussein AA. Assessment of cardiac and pulmonary function in
children with juvenile idiopathic arthritis. Rheumatology
International. 2010;32(1):39–46. doi:10.1007/s00296-010-1548-5